Sense About Statistics says: PACE trial doomed by flaws

Share on facebook
Share on twitter
Share on email

Dr Rebecca Goldin, blogging for Sense About Statistics, has said that flaws in the design of the PACE trial “were enough to doom its results from the start”.
Her 7,000-word post described the study’s design and the extensive changes to the planned analyses.
Dr Goldin, who is the Director of the organisation, writes, “The study is under increasing scrutiny by scientists and science writers about whether its conclusions are valid. The question of how all this happened and how the criticism is being handled have sent shockwaves through medicine”.
She added, “The results from PACE… have been published in prestigious journals and influenced public health recommendations around the world; and yet, unraveling this design and the characterization of the outcomes of the trial has left many people, including me, unsure this study has any scientific merit. How did the study go unchallenged for five years?”
Sense About Statistics is a collaboration between Sense About Science USA and the American Statistical Association. It is aimed particularly at journalists who need to understand statistics in order to accurately report the news. Dr Goldin’s analysis of the trial includes its media coverage as well as its design and statistical aspects.
She notes that “Patients pointed out flaws in the trial and asked for more data to analyze the claims, but their concerns were dismissed” until the appearance of Dr David Tuller’s analysis of the trial, which, she said, “described scientifically stunning problems”.
She reported that, now that 42 scientists have signed an open letter to The Lancet requesting independent re-analysis of the trial, the journal’s editor has invited the group to submit a letter about the concerns for publication.
Sense About Science’s director, Trevor Butterworth, accompanied the article with an editorial in which he described CFS as “a paralyzing syndrome that is as near to an off-switch on life as one can imagine”.
He wrote, “The reaction to patient criticism and Tuller’s story by the PACE researchers and the Lancet has been to deflect rather than to dissect… David Tuller may not get a Pulitzer Prize for investigating PACE trial on a blog; but his service to—and we do not exaggerate—millions of sufferers around the world make it hard for us to think of another work of journalism so deserving of commendation.”

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

1 thought on “Sense About Statistics says: PACE trial doomed by flaws”

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

NHS England omits advice to apply clinical judgement re vaccine

It has come to light that a letter from NHS England and NHS Improvement to all vaccination centres and GPs in the UK has omitted advice that health professionals can and should apply their clinical judgement when placing people in group 6. Vaccination of people with underlying health conditions that put them at risk of

Read More »
Waiting for Superman Book on table

Waiting for Superman – UK Book Giveaway and Review

Do you want to win a free copy of Waiting for Superman? We have three copies to give away to people in the UK!  To enter, all you have to do is follow #MEAction UK on Instagram, like and comment on this post. The deadline is 9am (GMT) Monday 8th March! Win a copy! Thank

Read More »
#MEAction activists outside Scottish Parliament

Scottish Election! Ask your MSPs to support people with ME

If you live in Scotland, please join our campaign to ask your MSPs to pledge their support for people with ME. Email your MSPs The Holyrood elections are coming up on 6 May 2021 and we want to make sure that MSPs are aware of ME and the desperate need for support. There are more

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top